Literature DB >> 10975592

Antiadrenergic effects of endothelin-1 on the L-type Ca2+ current in dog ventricular myocytes.

T Watanabe1, M Endoh.   

Abstract

The effect of endothelin-1 (ET-1) on L-type Ca2+ current (I(Ca)) and the interaction of ET-1 with beta-adrenergic stimulation were studied in dog ventricular myocytes by means of a whole-cell patch-clamp technique. ET-1 (10(-8) M) had no effect on the baseline I(Ca), but at 10(-9)-10(-7) M, it inhibited the isoproterenol (ISO)-induced increase in I(Ca). The maximal inhibition induced by ET-1 at 3 x 10(-8) M was approximately 30%, and the median inhibitory (IC50) value of ET-1 was 1.1 x 10(-9) M. The inhibitory action of ET-1 (10(-8) M) on the ISO-induced increase in I(Ca) was markedly attenuated by the ET(A) antagonist FR139317 (10(-6) M) and was partially inhibited by the ET(B) antagonist BQ-788 (10(-6) M). The inhibitory action of ET-1 was totally inhibited by the nonselective ET-receptor antagonist, TAK-044 (10(-6) M). These results indicate that ET-1 exerts an antiadrenergic effect on the ISO-induced increase in I(Ca), which is mediated mainly by ET(A), but activation of ET(B) receptors might contribute to the effect of ET-1 to a lesser extent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975592     DOI: 10.1097/00005344-200009000-00010

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

1.  Differential action of a protein tyrosine kinase inhibitor, genistein, on the positive inotropic effect of endothelin-1 and norepinephrine in canine ventricular myocardium.

Authors:  Li Chu; Jian-Xin Zhang; Ikuo Norota; Masao Endoh
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

Review 2.  The cardiovascular physiology and pharmacology of endothelin-1.

Authors:  Eric Thorin; Martine Clozel
Journal:  Adv Pharmacol       Date:  2010

3.  Mechanisms of endothelin-1-induced decrease in contractility in adult mouse ventricular myocytes.

Authors:  K Nishimaru; Y Miura; M Endoh
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

4.  Improvement in cardiac function of diabetic rats by bosentan is not associated with changes in the activation of PKC isoforms.

Authors:  Jihong Jiang; Violet Yuen; Hong Xiang; John H McNeill
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.842

Review 5.  Calcium signaling phenomena in heart diseases: a perspective.

Authors:  Sajal Chakraborti; Sudip Das; Pulak Kar; Biswarup Ghosh; Krishna Samanta; Saurav Kolley; Samarendranath Ghosh; Soumitra Roy; Tapati Chakraborti
Journal:  Mol Cell Biochem       Date:  2006-11-21       Impact factor: 3.842

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.